Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
Pharma Mar (PHMMF) Consolidated Net Income/Loss data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Consolidated Net Income/Loss |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$283.91M |
|
$63.42M |
|
$115.46M |
|
$399.37M |
|
$103.95M |
|
$42.75M |
|
$64.54M |
|
$168.50M |
|
$230.87M |
|
$229.45M |
|
$230.87M |
|
-- |
|
| Cash Flow Statement Financials | |
$22.85M |
|
$-3.02M |
|
$-33.77M |
|
$73.92M |
|
$58.13M |
|
$-15.79M |
|
-- |
|
$-16.30M |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|